Ronald J. Overmars

ORCID: 0000-0002-8984-0633
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • HIV Research and Treatment
  • HIV/AIDS drug development and treatment
  • HIV/AIDS Research and Interventions
  • SARS-CoV-2 and COVID-19 Research
  • Immune Response and Inflammation
  • Animal Virus Infections Studies
  • SARS-CoV-2 detection and testing
  • COVID-19 Clinical Research Studies
  • HIV-related health complications and treatments
  • Immune responses and vaccinations
  • T-cell and B-cell Immunology
  • Viral gastroenteritis research and epidemiology
  • CRISPR and Genetic Engineering
  • Viral Infections and Vectors
  • Viral Infections and Outbreaks Research
  • Immune Cell Function and Interaction
  • Mosquito-borne diseases and control
  • Immunotherapy and Immune Responses
  • interferon and immune responses

Erasmus MC
2018-2023

Erasmus University Rotterdam
2020-2023

University of Amsterdam
2016-2017

Amsterdam UMC Location University of Amsterdam
2016-2017

Institute of Infection and Immunity
2017

Bas B. Oude Munnink David F. Nieuwenhuijse M. L. STEIN Áine O’Toole Manon Haverkate and 82 more Madelief Mollers Sandra K. Kamga Claudia Schapendonk Mark Pronk Pascal Lexmond Anne van der Linden Theo M. Bestebroer Irina Chestakova Ronald J. Overmars Stefan van Nieuwkoop Richard Molenkamp Annemiek A. van der Eijk Corine H. GeurtsvanKessel Harry Vennema Adam Meijer Andrew Rambaut Jaap van Dissel Reina S. Sikkema Aura Timen Marion Koopmans G. J. A. P. M. Oudehuis Janke Schinkel Jan Kluytmans Marjolein Kluytmans-van den Bergh Wouter van den Bijllaardt Robbert G. Berntvelsen Miranda M. L. van Rijen Peter M. Schneeberger Suzan D. Pas B. M. W. Diederen Anneke Bergmans P. A. Verspui van der Eijk Jaco J. Verweij Anton G. N. Buiting Roel Streefkerk Albert P. Aldenkamp Peter de Man J. G. M. Koelemal Denise Rui Ying Ong S. Paltansing N. Veassen Jacqueline Sleven Leendert J. Bakker Heinrich Brockhoff Ariene Rietveld Fred Slijkerman Megelink James Cohen Stuart Anne de Vries Wil A. van der Reijden Axel Ros Esther B Lodder Ellen Verspui-van der Eijk Inge Huijskens E. M. Kraan M. P. M. van der Linden S. B. Debast Nashwan al Naiemi Aloys C.M. Kroes Marjolein Damen S. Dinant Sybren Lekkerkerk Oscar Pontesilli Pieter W. Smit Carla van Tienen Peggy C. R. Godschalk Jorien van Pelt Alewijn Ott Charlie van der Weijden Heiman Wertheim Janette Rahamat‐Langendoen Johan Reimerink Rogier Bodewes Erwin Duizer Bas van der Veer Chantal Reusken Suzanne P. M. Lutgens Peter M. Schneeberger Mirjam H. A. Hermans Peter C. Wever Alexander C. A. P. Leenders Henriëtte ter Waarbeek Christian J. P. A. Hoebe

10.1038/s41591-020-0997-y article EN other-oa Nature Medicine 2020-07-16

10 days after the first reported case of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in Netherlands (on Feb 27, 2020), 55 (4%) 1497 health-care workers nine hospitals located south had tested positive for SARS-CoV-2 RNA. We aimed to gain insight possible sources workers.We did a cross-sectional study at three Netherlands. screened participating infection, based on clinical symptoms (fever or mild symptoms) before screening. obtained epidemiological data through...

10.1016/s1473-3099(20)30527-2 article EN cc-by-nc-nd The Lancet Infectious Diseases 2020-07-02

Abstract Dengue virus (DENV) causes 400 million infections annually and is one of several viruses that can cause viral hemorrhagic fever, which characterized by uncontrolled immune activation resulting in high fever internal bleeding. Although the underlying mechanisms are unknown, massive cytokine secretion thought to be involved. Dendritic cells (DCs) main target DENV, we investigated their role DENV-induced production adaptive responses. DENV infection induced DC maturation IL-1β, IL-6,...

10.4049/jimmunol.1602121 article EN The Journal of Immunology 2017-05-16

Follicular T helper cells (TFH) are fundamental in orchestrating effective antibody-mediated responses critical for immunity against viral infections and vaccines. However, it is unclear how virus infection leads to TFH induction. We here show that dengue (DENV) of human dendritic (DCs) drives formation via crosstalk RIG-I-like receptor (RLR) RIG-I MDA5 with type I Interferon (IFN) signaling. DENV RLR-dependent IKKε activation, which phosphorylates IFNα/β receptor-induced STAT1 drive IL-27...

10.1371/journal.ppat.1006738 article EN cc-by PLoS Pathogens 2017-11-29

Abstract SARS-CoV-2 is a novel coronavirus that has rapidly spread across the globe. In Netherlands, first case of been notified on 27 th February. Here, we describe three weeks outbreak in which started with several different introductory events from Italy, Austria, Germany and France followed by local amplification in, later also, outside South Netherlands. The timely generation whole genome sequences combined epidemiological investigations facilitated early decision making an attempt to...

10.1101/2020.04.21.050633 preprint EN bioRxiv (Cold Spring Harbor Laboratory) 2020-04-25

Reactivation of the latent HIV-1 reservoir is a first step toward triggering decay. Here, we investigated impact BAF complex inhibitor pyrimethamine on people living with (PLWH). Twenty-eight PLWH suppressive antiretroviral therapy were randomized (1:1:1:1 ratio) to receive pyrimethamine, valproic acid, both, or no intervention for 14 days. The primary end point was change in cell-associated unspliced (CA US) RNA at days 0 and 14. We observed rapid, modest, significant increase response...

10.1126/sciadv.ade6675 article EN cc-by-nc Science Advances 2023-03-15
Bas B. Oude Munnink David F. Nieuwenhuijse M. L. STEIN Áine O’Toole Manon Haverkate and 82 more Madelief Mollers Sandra K. Kamga Claudia Schapendonk Mark Pronk Pascal Lexmond Anne van der Linden Theo M. Bestebroer Irina Chestakova Ronald J. Overmars Stefan van Nieuwkoop Richard Molenkamp Annemiek A. van der Eijk Corine H. GeurtsvanKessel Harry Vennema Adam Meijer Andrew Rambaut Jaap van Dissel Reina S. Sikkema Aura Timen Marion Koopmans G. J. A. P. M. Oudehuis Janke Schinkel Jan Kluytmans Marjolein Kluytmans-van den Bergh Wouter van den Bijllaardt Robbert G. Berntvelsen Miranda M. L. van Rijen Peter M. Schneeberger Suzan D. Pas B. M. W. Diederen Anneke Bergmans P. A. Verspui van der Eijk Jaco J. Verweij Anton G. N. Buiting Roel Streefkerk Albert P. Aldenkamp Peter de Man J. G. M. Koelemal David S. Y. Ong S. Paltansing N. Veassen Jacqueline Sleven Leendert J. Bakker Heinrich Brockhoff Ariene Rietveld Fred Slijkerman Megelink James Cohen Stuart Anne de Vries Wil A. van der Reijden Axel Ros Esther B Lodder Ellen Verspui-van der Eijk Inge Huijskens E. M. Kraan M. P. M. van der Linden S. B. Debast Nashwan al Naiemi Aloys C.M. Kroes Marjolein Damen S. Dinant Sybren Lekkerkerk Oscar Pontesilli Pieter W. Smit Carla van Tienen Peggy C. R. Godschalk Jorien van Pelt Alewijn Ott Charlie van der Weijden Heiman Wertheim Janette Rahamat‐Langendoen Johan Reimerink Rogier Bodewes Erwin Duizer Bas van der Veer Chantal Reusken Suzanne P. M. Lutgens Peter M. Schneeberger Mirjam H. A. Hermans Peter C. Wever Alexander C. A. P. Leenders Henriëtte ter Waarbeek Christian J. P. A. Hoebe

An amendment to this paper has been published and can be accessed via a link at the top of paper.

10.1038/s41591-020-1128-5 article EN other-oa Nature Medicine 2020-10-20

Substantial efforts to eliminate or reduce latent HIV-1 reservoirs are underway in clinical trials and have created a critical demand for sensitive, accurate, reproducible tools evaluate the efficacy of these strategies. Alternative reservoir quantification assays been developed circumvent limitations quantitative viral outgrowth assay. One such assay is tat/rev induced limiting dilution (TILDA), which measures frequency CD4+ T cells harboring inducible provirus. We modified...

10.3390/v12090973 article EN cc-by Viruses 2020-09-02

We report a case of incomplete HIV-1 suppression on dolutegravir, lamivudine, and abacavir single-tablet regimen with the emergence H51Y G118R integrase resistance mutations. Integrase sequencing was performed retrospectively by Sanger next-generation sequencing. Rates decline mutations were calculated using data. Dolutegravir plasma concentrations measured ultra-performance liquid chromatography-tandem mass spectrometry. The effects infectivity, fitness, susceptibility to dolutegravir...

10.1016/j.jgar.2022.11.001 article EN cc-by Journal of Global Antimicrobial Resistance 2022-11-05

Abstract Ten days after the first reported case of SARS-CoV-2 infection in Netherlands, 3.9% healthcare workers (HCWs) nine hospitals located South Netherlands tested positive for RNA. The extent nosocomial transmission that contributed to HCW infections was unknown. We combined epidemiological data, collected by means structured interviews HCWs, with whole genome sequencing (WGS) clinical samples from HCWs and patients three participated screening, perform an in-depth analysis sources modes...

10.1101/2020.04.26.20079418 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2020-05-01

Although some individuals with HIV-2 develop severe immunodeficiency and AIDS-related complications, most may never progress to AIDS. Replication-competent isolated from asymptomatic long-term non-progressors (controllers) have lower replication rates than viruses who AIDS (progressors). To investigate potential retroviral factors that correlate disease progression in HIV-2, we sequenced the near full-length genomes of replication-competent previously outgrown controllers progressors used...

10.3390/v15112236 article EN cc-by Viruses 2023-11-09

Abstract A major barrier towards HIV-1 cure is the presence of a replication-competent latent reservoir that, upon treatment cessation, can spark viral rebound leading to disease progression. Pharmacological reactivation with Latency reversing agents (LRAs) first step toward triggering decay. Inhibitors BAF-complex, key repressor transcription were identified act as LRAs, and enhanced effect other LRAs such histone deacetylase inhibitors ex-vivo. We repurposed licensed drug pyrimethamine...

10.1101/2022.09.23.22280188 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2022-09-23
Coming Soon ...